[unable to retrieve full-text content]Ranbaxy, which had more than 40 percent of the United States market for generic Lipitor in October, said it had been working with the F.D.A. to solve quality problems in making the drug.
Source: http://www.nytimes.com/2013/02/23/business/statin-drug-production-resumes-at-ranbaxy.html?partner=rss&emc=rss
unclaimed money godspell media matters hana taylor momsen xbox live update joan rivers
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.